Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases (Q39421189)

11 September 2017

title

Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases (English)

1 reference

inflammatory bowel diseases

11 September 2017

main subject

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27596694%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Ray Boyapati

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27596694%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Gwo-Tzer Ho

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27596694%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

12

Jack Satsangi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27596694%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

8

Hazel Drummond

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27596694%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

6

Elaine R Nimmo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27596694%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1

Rahul Kalla

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27596694%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

3

Nicholas T Ventham

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27596694%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Alex T Adams

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27596694%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Micaela R Visconti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27596694%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Rebecca J Pattenden

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27596694%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

David C Wilson

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27596694%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

English

0 references

publication date

6 September 2016

1 reference

The American Journal of Gastroenterology

11 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27596694%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27596694%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27596694%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

1796-1805

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27596694%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

The burden of inflammatory bowel disease in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Biomarkers of Inflammation in Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

The role and utility of faecal markers in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Fecal calprotectin predicts the clinical course of acute severe ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Serum calprotectin as a biomarker for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Measurement of serum calprotectin in stable patients predicts exacerbation and lung function decline in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Calprotectin as a biomarker for rheumatoid arthritis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Identification of S100A9 as biomarker of responsiveness to the methotrexate/etanercept combination in rheumatoid arthritis using a proteomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Serum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

pROC: an open-source package for R and S+ to analyze and compare ROC curves

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

S100A8 and S100A9 in cardiovascular biology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Comparison of gene expression profiles between human and mouse monocyte subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Serum protein markers for early detection of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

An approach to studying lung cancer-related proteins in human blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Prospective population-based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn's disease: a marker for patient classification?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.342

Classification of inflammatory bowel disease

21 January 2018

1 reference

12 December 2020

Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16-50 years

1 reference

12 December 2020

Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI

1 reference

12 December 2020

Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices

1 reference

12 December 2020

Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis

1 reference

12 December 2020

The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis

1 reference

12 December 2020

1 reference

12 December 2020

Sputum and serum calprotectin are useful biomarkers during CF exacerbation

1 reference

12 December 2020

Serum calprotectin: review of its usefulness and validity in paediatric rheumatic diseases.

1 reference

12 December 2020

Predictors of Crohn's disease

1 reference

12 December 2020

The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States

1 reference

12 December 2020

High within-day variability of fecal calprotectin levels in patients with active ulcerative colitis: what is the best timing for stool sampling?

1 reference

12 December 2020

Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine

1 reference

12 December 2020

Increase in plasma calprotectin during long-distance running

1 reference

12 December 2020

Serum C-reactive protein and CRP genotype in pediatric inflammatory bowel disease: influence on phenotype, natural history, and response to therapy

1 reference

12 December 2020

Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease

1 reference

12 December 2020

The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study

1 reference

12 December 2020

Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease

1 reference

12 December 2020